Fig. 10From: Thymoquinone, piperine, and sorafenib combinations attenuate liver and breast cancers progression: epigenetic and molecular docking approachesCo-crystallized ligands redocked in vascular endothelial growth factor receptor-2 (VEGFR-2), hydrogen bonds (green) and the pi interactions are represented in purple lines with mapping surface showing thymoquinone (TQ), piperine (PIP), and sorafenib (SOR) occupying the active pocket of VEGFR-2Back to article page